B-cell depleters attenuate the humoral response to SARS-CoV-2 vaccines in multiple sclerosis patients: A case-control study.

Conte, William L

Conte, William L.

Affiliation

Conte WL; Comprehensive MS Center, Methodist Hospitals, 200 E 89th Ave, Merrillville IN 46410, United States. Electronic address: Billy.conte@gmail.com.

Mult Scler Relat Disord ; 57: 103413, 2022 Jan.

Article in En | MEDLINE | ID: mdl-35158480

Subject(s)

COVID-19; Multiple Sclerosis; Antibodies, Viral; COVID-19 Vaccines; Case-Control Studies; Humans; SARS-CoV-2; Spike Glycoprotein, Coronavirus

Key words

COVID-19; Disease modifying therapies; Ocrelizumab; SARS-CoV-2; Vaccine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: Mult Scler Relat Disord Year: 2022 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google